Adapting asthma clinical trials in response to the COVID-19 pandemic - the BenRex study design

S. Smith (Glasgow, United Kingdom), L. Gillespie (Glasgow, United Kingdom), L. Heaney (Belfast, United Kingdom), C. Brightling (Leicester, United Kingdom), A. Mcconnachie (Glasgow, United Kingdom), S. Siddiqui (Lecester, United Kingdom), V. Mistry (Lecester, United Kingdom), V. Brown (Belfast, United Kingdom), D. Jackson (London, United Kingdom), N. Lee (Glasgow, United Kingdom), S. Fowler (Manchester, United Kingdom), A. Mansur (Birmingham, United Kingdom), H. Burhan (Liverpool, United Kingdom), D. Saralaya (Bradford, United Kingdom), R. Kurukulaaratchy (Southampton, United Kingdom), S. Nasser (Cambridge, United Kingdom), P. Pfeffer (London, United Kingdom), T. Brown (Portsmouth, United Kingdom), J. Lordan (Newcastle, United Kingdom), I. Pavord (Oxford, United Kingdom), R. Chaudhuri (Glasgow, United Kingdom)

Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Smith (Glasgow, United Kingdom), L. Gillespie (Glasgow, United Kingdom), L. Heaney (Belfast, United Kingdom), C. Brightling (Leicester, United Kingdom), A. Mcconnachie (Glasgow, United Kingdom), S. Siddiqui (Lecester, United Kingdom), V. Mistry (Lecester, United Kingdom), V. Brown (Belfast, United Kingdom), D. Jackson (London, United Kingdom), N. Lee (Glasgow, United Kingdom), S. Fowler (Manchester, United Kingdom), A. Mansur (Birmingham, United Kingdom), H. Burhan (Liverpool, United Kingdom), D. Saralaya (Bradford, United Kingdom), R. Kurukulaaratchy (Southampton, United Kingdom), S. Nasser (Cambridge, United Kingdom), P. Pfeffer (London, United Kingdom), T. Brown (Portsmouth, United Kingdom), J. Lordan (Newcastle, United Kingdom), I. Pavord (Oxford, United Kingdom), R. Chaudhuri (Glasgow, United Kingdom). Adapting asthma clinical trials in response to the COVID-19 pandemic - the BenRex study design. 1108

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical trials during the COVID-19 pandemic: research design and lessons
Source: Eur Respir Monogr 2021; 94: 214-231
Year: 2021


A non-interventional observational trial to study the COPD treatment choices in routine clinical practice in Bulgaria
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016


ISARIC Covid-19 pandemic research response, tools and outcomes from clinical characterisation studies
Source: Virtual Congress 2020 – New developments in pandemic medicine
Year: 2020


The Spanish national clinical audit on COPD exacerbations (eCOPD). Pilot study: selection of study subjects
Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD
Year: 2008


A trial like ALIC4E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness?
Source: ERJ Open Res, 4 (2) 00046-2018; 10.1183/23120541.00046-2018
Year: 2018



A smart mHealth tool versus a paper action plan to support self-management of COPD exacerbations: a randomised controlled trial
Source: International Congress 2019 – M-health/e-health I
Year: 2019

New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response
Source: Eur Respir Rev 2014; 23: 367-378
Year: 2014



Negative clinical trials in sarcoidosis: failed therapies or flawed study design?
Source: Eur Respir J 2014; 44: 1123-1126
Year: 2014


The Spanish national clinical audit on COPD exacerbations. Results of a pilot study: main outcomes
Source: Annual Congress 2008 - Prognosis in COPD
Year: 2008


A personalised management programme of difficult asthma: a prospective study
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007


COPD integrated disease management, from controlled trial to real-world primary care; a cohort study.
Source: Virtual Congress 2020 – Organising respiratory disease management in primary care
Year: 2020


Effectiveness versus efficacy trials in COPD: how study design influences outcomes and applicability
Source: Eur Respir J, 51 (2) 1701531; 10.1183/13993003.01531-2017
Year: 2018



No gender-related bias in COPD diagnosis and treatment in Sweden: a randomised, controlled, case-based trial
Source: ERJ Open Res, 6 (4) 00342-2020; 10.1183/23120541.00342-2020
Year: 2020



Clinical effectiveness of self-management of asthma in general practice: a randomized controlled trial
Source: Eur Respir J 2001; 18: Suppl. 33, 518s
Year: 2001

The long-term clinical and economic impact of COPD exacerbations: an observational study (SHERLOCK)
Source: Virtual Congress 2020 – Prediction and management of outcomes in obstructive diseases
Year: 2020




The Spanish national clinical audit on COPD exacerbations. results of a pilot study: spirometry outcomes
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008


The coping with asthma study: a randomised controlled trial and economic evaluation of a home-based nurse intervention for adults at risk of adverse asthma outcomes
Source: Eur Respir J 2003; 22: Suppl. 45, 536s
Year: 2003

Quality and methodology of clinical practice guidelines on antiviral pharmacotherapy for COVID-19 during the early phase of the pandemic
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021